A Phase III Multi-Institutional Randomized Study of Immunization with the Gp100: 209-217(210M) Peptide Followed By High Dose IL-2 Compared with High Dose IL-2 Alone in Patients with Metastatic Melanoma in J Clin Oncol

Publication Type
Conference Paper
Year of Publication
2009
Authors
Schwartzentruber, D; Lawson, D; Richards, J; Conry, R; Miller, D; Triesman, J; Gailani, F; Riley, LB; Vena, D; Hwu, P
Secondary
45th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Date Published
05/2009
Location
Orlando FL
Publisher
American Society of Clinical Oncology